180 related articles for article (PubMed ID: 30949407)
41. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
[TBL] [Abstract][Full Text] [Related]
42. Licochalcone H Targets EGFR and AKT to Suppress the Growth of Oxaliplatin -Sensitive and -Resistant Colorectal Cancer Cells.
Lee SO; Lee MH; Kwak AW; Lee JY; Yoon G; Joo SH; Choi YH; Park JW; Shim JH
Biomol Ther (Seoul); 2023 Nov; 31(6):661-673. PubMed ID: 37899744
[TBL] [Abstract][Full Text] [Related]
43. Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2.
Chen Y; Fang L; Zhang J; Li G; Ma M; Li C; Lyu J; Meng QH
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282916
[TBL] [Abstract][Full Text] [Related]
44. Sulfatase-2 promotes the growth and metastasis of colorectal cancer by activating Akt and Erk1/2 pathways.
Tao Y; Han T; Zhang T; Sun C
Biomed Pharmacother; 2017 May; 89():1370-1377. PubMed ID: 28320104
[TBL] [Abstract][Full Text] [Related]
45. Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation.
Chowdhury AMMA; Katoh H; Hatanaka A; Iwanari H; Nakamura N; Hamakubo T; Natsume T; Waku T; Kobayashi A
Sci Rep; 2017 Oct; 7(1):12494. PubMed ID: 28970512
[TBL] [Abstract][Full Text] [Related]
46. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells.
Adachi S; Shimizu M; Shirakami Y; Yamauchi J; Natsume H; Matsushima-Nishiwaki R; To S; Weinstein IB; Moriwaki H; Kozawa O
Carcinogenesis; 2009 Sep; 30(9):1544-52. PubMed ID: 19578043
[TBL] [Abstract][Full Text] [Related]
47. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
48. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
[TBL] [Abstract][Full Text] [Related]
49. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
50. TES inhibits colorectal cancer progression through activation of p38.
Li H; Huang K; Gao L; Wang L; Niu Y; Liu H; Wang Z; Wang L; Wang G; Wang J
Oncotarget; 2016 Jul; 7(29):45819-45836. PubMed ID: 27323777
[TBL] [Abstract][Full Text] [Related]
51. Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo.
Qin AC; Li Y; Zhou LN; Xing CG; Lu XS
Cell Physiol Biochem; 2019; 52(4):758-768. PubMed ID: 30933440
[TBL] [Abstract][Full Text] [Related]
52. ERBB4 is over-expressed in human colon cancer and enhances cellular transformation.
Williams CS; Bernard JK; Demory Beckler M; Almohazey D; Washington MK; Smith JJ; Frey MR
Carcinogenesis; 2015 Jul; 36(7):710-8. PubMed ID: 25916654
[TBL] [Abstract][Full Text] [Related]
53. Role of TXNDC5 in tumorigenesis of colorectal cancer cells: In vivo and in vitro evidence.
Tan F; Zhu H; He X; Yu N; Zhang X; Xu H; Pei H
Int J Mol Med; 2018 Aug; 42(2):935-945. PubMed ID: 29749460
[TBL] [Abstract][Full Text] [Related]
54. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
[TBL] [Abstract][Full Text] [Related]
55. Functional and placental expression analysis of the human NRF3 transcription factor.
Chénais B; Derjuga A; Massrieh W; Red-Horse K; Bellingard V; Fisher SJ; Blank V
Mol Endocrinol; 2005 Jan; 19(1):125-37. PubMed ID: 15388789
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of miR-301a-3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer-1 and runt-related transcription factor 3.
Zhang L; Zhang Y; Zhu H; Sun X; Wang X; Wu P; Xu X
J Cell Biochem; 2019 Apr; 120(4):6078-6089. PubMed ID: 30362160
[TBL] [Abstract][Full Text] [Related]
57. ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.
Yan W; Bai Z; Wang J; Li X; Chi B; Chen X
Oncol Rep; 2017 Sep; 38(3):1605-1612. PubMed ID: 28731192
[TBL] [Abstract][Full Text] [Related]
58. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
59. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
60. Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer.
Zhang Z; Chen Z; Song Y; Zhang P; Hu J; Bai C
J Pathol; 2010 Jun; 221(2):210-20. PubMed ID: 20455256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]